India CDSCO Proposes Faster Medical Device License Timelines

India's Central Drugs Standard Control Organisation (CDSCO) has published a draft amendment to shorten the approval timelines for medical device manufacturing licenses. This episode details the proposed reductions for Class B, C, and D devices, effective from the draft publication on June 28, 2024. We explore the rationale behind this move to improve regulatory efficiency and discuss the direct impact on manufacturers' market access strategies. Learn practical steps your regulatory and quality teams can take now to prepare for these accelerated timelines and leverage them for a competitive advantage in the Indian market. Key Questions: - What are the specific proposed timeline reductions for medical device manufacturing licenses in India? - Which device classes (Class B, C, D) are affected by this CDSCO draft amendment? - Why is the Indian government proposing to speed up the regulatory approval process? - How does this change impact market access strategy for MedTech companies targeting India? - What is the significance of the June 28, 2024, notification from the Ministry of Health and Family Welfare? - What steps can manufacturers take now to prepare for these faster review timelines? - How can a complete and accurate submission help maximize the benefits of a shorter review period? - What is the role of a local representative in navigating these updated regulations? Sources: - https://pib.gov.in/PressReleasePage.aspx?PRID=2029517 - https://medtech.citeline.com/MT152643/India-Proposes-Faster-Medical-Device-Manufacturing-License-Timelines How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies, streamlining global market access. We act as your local representative in over 30 markets, including India, and develop efficient regulatory strategies to accelerate approvals. Our experts use advanced AI to compile and manage technical dossiers, ensuring high-quality submissions that meet CDSCO requirements. We help you navigate regulatory changes, maintain compliance through post-market surveillance, and turn complex requirements into market opportunities. To learn how we can accelerate your entry into the Indian market, visit us at https://pureglobal.com, contact us at [email protected], or explore our free AI tools and device database at https://pureglobal.ai.